Effect of secretory DKK3 on circulating CD56bright natural killer cells in patients with liver cancer

被引：0
|
作者：
Liu, Da-Hua [1 ]
Wen, Gui-Min [2 ]
Song, Chang-Liang [3 ]
Xia, Pu [1 ,4 ]
机构：
[1] Jinzhou Med Univ, Biol Anthropol Inst, Coll Basic Med Sci, Jinzhou, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Coll Nursing, Dept Community Nursing, Jinzhou, Liaoning, Peoples R China
[3] Ctr Hosp Handan, Dept Radiotherapy, Handan, Hebei, Peoples R China
[4] Jinzhou Med Univ, Biol Anthropol Inst, Jinzhou 121000, Liaoning, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS | 2023年 / 38卷 / 02期
基金：
中国国家自然科学基金;
关键词：
Liver cancer; DKK3; NK cells; differentiation; cytotoxicity; NK CELLS; METHYLATION; EXPRESSION; MECHANISM; ALPHA;
D O I：
10.1177/03936155231169796
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Background Liver cancer seriously threatens human health. Natural killer (NK) cells are an important part of the innate immune system and have strong anti-tumor ability. Immunotherapy based on NK cells has become a hot topic in the treatment of liver cancer. Methods In this study, we checked the serum DKK3 (sDKK3) and circulating CD56(bright) NK cells using ELISA and flow cytometry, respectively, in the blood of liver cancer patients. The effect on recombinant human DKK3 (rhDKK3) on CD56(bright) NK cells was analyzed in vitro. Results We found low levels of sDKK3 in liver cancer patients and a negative correlation between sDKK3 and circulating CD56(bright) NK cells. In addition, we found that DKK3 induced the differentiation and improved the cytotoxicity of CD56(bright) NK cells for the first time. It could be used as an agonist for NK cell-based immunotherapy. Conclusions Improving the clinical efficacy of NK cells through DKK3 will become a new strategy for cancer immunotherapy.
引用
收藏
页码：99 / 104
页数：6
相关论文
共 50 条
  • [21] Double-bright (CD56bright/CD16bright) natural killer cell adoptive immunotherapy for SARS-CoV-2
    Silla, Lucia
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (06) : e322 - e323
  • [22] Distinct Natural Killer Cells in HIV-Exposed Seronegative Subjects With Effector Cytotoxic CD56dim and CD56bright Cells and Memory-Like CD57+NKG2C+CD56dim Cells
    Lima, Josenilson F.
    Oliveira, Luanda M. S.
    Pereira, Natalli Z.
    Mitsunari, Gabrielle E.
    Duarte, Alberto J. S.
    Sato, Maria N.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (05) : 463 - 471
  • [23] Differential alteration of CD56bright and CD56dim natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
    Miyagi, Takuya
    Shimizu, Satoshi
    Tatsumi, Tomohide
    Nishio, Kumiko
    Hiramatsu, Naoki
    Kanto, Tatsuya
    Hayashi, Norio
    Takehara, Tetsuo
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (08) : 1020 - 1030
  • [24] Adoptive immunotherapy with double-bright (CD56bright/CD16bright) expanded natural killer cells in patients with relapsed or refractory acute myeloid leukaemia: a proof-of-concept study
    Silla, Lucia
    Valim, Vanessa
    Pezzi, Annelise
    da Silva, Maria
    Wilke, Ianae
    Nobrega, Juliana
    Vargas, Alini
    Amorin, Bruna
    Correa, Bruna
    Zambonato, Bruna
    Scherer, Fernanda
    Merzoni, Joice
    Sekine, Leo
    Huls, Helen
    Cooper, Laurence J.
    Paz, Alessandra
    Lee, Dean A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (05) : 710 - 721
  • [25] Differential alteration of CD56bright and CD56dim natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection
    Takuya Miyagi
    Satoshi Shimizu
    Tomohide Tatsumi
    Kumiko Nishio
    Naoki Hiramatsu
    Tatsuya Kanto
    Norio Hayashi
    Tetsuo Takehara
    Journal of Gastroenterology, 2011, 46
  • [26] CD300c is uniquely expressed on CD56bright Natural Killer Cells and differs from CD300a upon ligand recognition
    Dimitrova, Milena
    Zenarruzabeitia, Olatz
    Borrego, Francisco
    Simhadri, Venkateswara R.
    SCIENTIFIC REPORTS, 2016, 6
  • [27] The Transcription Factor Promyelocytic Leukemia Zinc Finger Protein Is Associated With Expression of Liver-Homing Receptors on Human Blood CD56bright Natural Killer Cells
    Hess, Leonard U.
    Martrus, Gloria
    Ziegler, Annerose E.
    Langeneckert, Annika E.
    Salzberger, Wilhelm
    Goebels, Hanna
    Sagebiel, Adrian F.
    Hagen, Sven H.
    Poch, Tobias
    Ravichandran, Gevitha
    Koch, Martina
    Schramm, Christoph
    Oldhafer, Karl J.
    Fischer, Lutz
    Tiegs, Gisa
    Richert, Laura
    Bunders, Madeleine J.
    Lunemann, Sebastian
    Altfeld, Marcus
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (03) : 409 - 424
  • [28] Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells
    Allan, David S. J.
    Cerdeira, Ana Sofia
    Ranjan, Anuisa
    Kirkham, Christina L.
    Aguilar, Oscar A.
    Tanaka, Miho
    Childs, Richard W.
    Dunbar, Cynthia E.
    Strominger, Jack L.
    Kopcow, Hernan D.
    Carlyle, James R.
    SCIENTIFIC REPORTS, 2017, 7
  • [29] CD27 engagement by a soluble CD70 protein enhances non-cytolytic antiviral activity of CD56bright natural killer cells by IFN-γ secretion
    Jang, Young-Soon
    Kang, Wonseok
    Chang, Dong-Yeop
    Sung, Pil Soo
    Park, Bum-Chan
    Yoo, Seok Ho
    Park, Young Woo
    Shin, Eui-Cheol
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 379 - 387
  • [30] Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer
    Khan, Md Abdullah Al Kamran
    Sedgwick, Alexander James
    Sun, Yuhan
    Vivian, Julian P.
    Corbett, Alexandra J.
    Dolcetti, Riccardo
    Mantamadiotis, Theo
    Mangiola, Stefano
    Barrow, Alexander David
    FRONTIERS IN IMMUNOLOGY, 2025, 15
12345